Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 409Observational 3Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Myeloid 1

Conditions

Breast Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma 3Myelodysplastic Syndromes 2Unspecified Childhood Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Recurrence 1Pancreatic Neoplasms 1Ototoxicity 1Neurotoxicity Syndromes 1Neoplasm, Residual 1Neoplasm Metastasis 1Myasthenia Gravis 1Multiple Myeloma 1Microbiota 1Metabolic Diseases 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Immunologic Deficiency Syndromes 1Immunoglobulin Light-chain Amyloidosis 1Hormone Refractory Prostate Cancer 1Fatigue 1Central Nervous System Neoplasms 1Breast Cancer Organoids 1Breast Cancer Metastatic 1Brain Neoplasms 1

Interventions

Psychiatric Rehabilitation 7Flow Cytometry 6Therapeutics 5Surveys and Questionnaires 5Microarray Analysis 5Gene Expression Profiling 5Vincristine 4Polymerase Chain Reaction 4Methotrexate 4Daunorubicin 4Cytogenetic Analysis 4Amplified Fragment Length Polymorphism Analysis 4ponatinib 3fludarabine 3Watchful Waiting 3Prednisone 3Observation 3Mercaptopurine 3Interviews as Topic 3Inotuzumab Ozogamicin 3Immunologic Techniques 3Immunoenzyme Techniques 3Cytarabine 3Cyclophosphamide 3tisagenlecleucel 2pegaspargase 2fish oil triglycerides 2blinatumomab 2In Situ Hybridization, Fluorescence 2Imatinib Mesylate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Cyclophosphamide × Clear all
NCT05959720 2025-05-07

BRALLA

Instituto do Cancer do Estado de São Paulo

Recruiting
180 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06175702 2023-12-19

LALPh2022

PETHEMA Foundation

Not yet recruiting
150 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02328950 2016-02-17

A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome

Fujian Medical University

Unknown
50 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡